Pharmaron Beijing Co., Ltd. (3759.HK)
Develops and manufactures drugs and drug ingredients for pharmaceutical companies worldwide.
23.10-0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+6.0%
The outlook
Analysts overwhelmingly rate 3759.HK a Strong Buy, with an average price target about 33% above the current price of 23.1. The stock is trading above both its 50- and 200-day moving averages and sits midway through its 52-week range, suggesting a stable uptrend. At a trailing P/E of 21, the valuation appears fairly positioned relative to the analyst enthusiasm.
What’s behind the score
Analyst consensusStrong Buy — 1.2 avg of 12 analysts
Price trendAbove its 50- & 200-day averages
52-week range55% of the way from its 52-week low to high
Price targetAvg target +33% vs current price
Analyst price target
~12-month · 12 analysts30.76average target+33.1% vs now
Now 23.10
Low 25.54High 45.47
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$42.44B
52-wk high
30.12
52-wk low
14.45
50-day avg
18.94
200-day avg
20.72
Trailing P/E
21.0